OTC Markets OTCPK - Delayed Quote USD
RAKOVINA THERAPEUTICS INC (RKVTF)
0.0360
-0.0001
(-0.28%)
As of April 23 at 1:45:29 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
3,054.6890
2,482.1000
2,817.4790
2,474.3300
Operating Income
-3,054.6890
-2,482.1000
-2,817.4790
-2,474.3300
Net Non Operating Interest Income Expense
-254.6730
-128.9390
28.2750
8.5390
Other Income Expense
-2.0300
-1.8850
-2.0300
-3,055.3480
Pretax Income
-3,311.3920
-2,612.9240
-2,791.2340
-5,521.1390
Net Income Common Stockholders
-3,311.3930
-2,612.9250
-2,791.2340
-5,521.1390
Diluted NI Available to Com Stockholders
-3,311.3930
-2,612.9250
-2,791.2340
-5,521.1390
Basic EPS
-0.04
-0.04
-0.04
-0.10
Diluted EPS
-0.04
-0.04
-0.04
-0.10
Basic Average Shares
74,971.3720
69,848.3940
69,828.7940
53,622.7340
Diluted Average Shares
74,971.3720
69,848.3940
69,828.7940
53,622.7340
Rent Expense Supplemental
34.7340
42
38.5000
30
Total Expenses
3,054.6890
2,482.1000
2,817.4790
2,474.3300
Net Income from Continuing & Discontinued Operation
-3,311.3930
-2,612.9250
-2,791.2340
-5,521.1390
Normalized Income
-3,309.3630
-2,611.0400
-2,789.2040
-2,465.7910
Interest Income
9.7960
22.3700
28.2750
8.5390
Interest Expense
264.4690
151.3090
--
--
Net Interest Income
-254.6730
-128.9390
28.2750
8.5390
EBIT
-3,046.9230
-2,461.6150
-2,791.2340
-2,474.3300
EBITDA
-2,509.3450
-1,925.5060
-2,255.1250
-2,061.5990
Reconciled Depreciation
537.5780
536.1090
536.1090
412.7310
Net Income from Continuing Operation Net Minority Interest
-3,311.3930
-2,612.9250
-2,791.2340
-5,521.1390
Total Unusual Items Excluding Goodwill
-2.0300
-1.8850
-2.0300
-3,055.3480
Total Unusual Items
-2.0300
-1.8850
-2.0300
-3,055.3480
Normalized EBITDA
-2,507.3150
-1,923.6210
-2,253.0950
993.7490
12/31/2021 - 4/8/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYCCP Cyclacel Pharmaceuticals, Inc.
4.8700
+1.46%
MNOV MediciNova, Inc.
1.4600
-2.01%
GYRE Gyre Therapeutics, Inc.
9.11
-0.87%
TECH Bio-Techne Corporation
50.61
+0.90%
TCRT Alaunos Therapeutics, Inc.
2.6500
+7.82%
LEXX Lexaria Bioscience Corp.
1.5532
-2.31%
ADVM Adverum Biotechnologies, Inc.
2.9900
+4.91%
ZVSA ZyVersa Therapeutics, Inc.
0.7339
+4.23%
SVA.TO Sernova Biotherapeutics Inc
0.2200
0.00%
DRMA Dermata Therapeutics, Inc.
0.7710
-2.70%